Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis og 579 patients treated with epirubicin-based chemoterapy

Research output: Contribution to journalJournal articleResearchpeer-review

breast cancer; CNS metastases; competing risk analysis; epirubicin; lactate dehydrogenase; predictive factor
Original languageEnglish
JournalBreast Cancer Research and Treatment
Issue number91
Pages (from-to)217-225
ISSN0167-6806
Publication statusPublished - 2005

ID: 93399